Aripiprazole treatment causes extrapyramidal side effects but not prolactin elevation: a disconnect of the striatal D2 occupancy story: case report.
Shim
Joo-Cheol
JC
You
Young-Sun
YS
Kelly
Deanna L
DL
D000328:Adult; D017109:Akathisia, Drug-Induced / Q000188:drug therapy / Q000503:physiopathology*; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000068180:Aripiprazole; D001590:Benztropine / Q000627:therapeutic use; D003342:Corpus Striatum / Q000187:drug effects* / Q000503:physiopathology; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008297:Male; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use; D011388:Prolactin / Q000097:blood*; D015363:Quinolones / Q000009:adverse effects* / Q000627:therapeutic use; D017448:Receptors, Dopamine D2 / Q000187:drug effects* / Q000502:physiology; D012559:Schizophrenia / Q000188:drug therapy* / Q000503:physiopathology
D014150:Antipsychotic Agents; D010879:Piperazines; D015363:Quinolones; D017448:Receptors, Dopamine D2; D001590:Benztropine; D000068180:Aripiprazole; D011388:Prolactin